Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Snynf crawled date : 2022 - 12 - 15 save search
Optinose Appoints Paul Spence as Chief Commercial Officer
Published: 2022-12-15 (Crawled : 22:00) - globenewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -1.49%
H: 0.0%
C: 0.0%
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: -2.35%
H: 0.0%
C: 0.0%
OPTN | $1.005 -2.43% 320K
|
Health Services
|
| O: -4.0%
H: 5.95%
C: 1.19%
commercial
Global Rare Disease Drugs Market Report 2022-2027: Increasing Focus on Research Activities and Development of Novel Therapeutic Drugs to Facilitate Future Growth
Published: 2022-12-15 (Crawled : 18:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
TAK | News | $13.41 0.37% 1M
|
Health Technology
|
| O: -0.71%
H: 0.07%
C: -1.05%
NVS | News | $97.31 2.3% 2.3M
|
Health Technology
|
| O: -0.71%
H: 0.08%
C: -1.07%
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: -0.59%
H: 0.44%
C: -0.48%
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: 0.0%
rare research global disease report growth market
Gilgamesh Pharmaceuticals Raises $39 Million Series B to Advance Mental Health Treatments
Published: 2022-12-15 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: 0.0%
pharmaceuticals health
Alnylam Announces 2023 Product and Pipeline Goals and Provides Program Updates at R&D Day
Published: 2022-12-15 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: 0.0%
ALNY | $145.9 0.08% 230K
|
Health Technology
|
| O: -0.39%
H: 0.0%
C: -1.56%
day program
Press Release: Dupixent® (dupilumab) approved by European Commission as the first and only targeted medicine indicated for prurigo nodularis
Published: 2022-12-15 (Crawled : 08:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: 0.0%
REGN | News | $908.42 0.92% 130K
|
Health Technology
|
| O: -0.24%
H: 0.0%
C: -2.26%
dupixent approved
Dupixent® (dupilumab) Approved by European Commission as the First and Only Targeted Medicine Indicated for Prurigo Nodularis
Published: 2022-12-15 (Crawled : 08:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: 0.0%
REGN | News | $908.42 0.92% 130K
|
Health Technology
|
| O: -0.24%
H: 0.0%
C: -2.26%
dupixent approved
Everest Medicines Announces New mRNA Rabies Vaccine Program and Achievement of Preclinical Proof-of-Concept Milestone Everest Medicines announced that the company has achieved the preclinical proof-of-...
Published: 2022-12-15 (Crawled : 08:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: 0.0%
PRTA 4 | $20.88 -1.93% 180K
|
Health Technology
|
| O: 0.97%
H: 7.04%
C: -0.02%
MTP | $0.4703 -70.79% -73.69% 0
|
Health Technology
|
| O: -4.03%
H: 2.0%
C: -15.78%
preclinical vaccine program mrna milestone
Innovent and LG Chem Announce Strategic Collaboration for Tigulixostat, a Novel Non-Purine Xanthine Oxidase Inhibitor for the Treatment of Gout Disease
Published: 2022-12-15 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
LLY | News | $744.47 1.8% 1M
|
Health Technology
|
| O: -0.78%
H: 0.92%
C: -0.18%
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: 0.0%
INCY | $52.02 0.19% 1.2M
|
Health Technology
|
| O: -0.83%
H: 0.66%
C: 0.3%
treatment disease collaboration
Sinusitis drugs market size to increase by USD 801.39 million: 40% growth to originate from North America - Technavio
Published: 2022-12-14 (Crawled : 00:00) - prnewswire.com
GLAXF | News | $20.305 630
|
Health Technology
|
| O: -1.57%
H: 2.23%
C: 2.23%
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
NVS | News | $97.31 2.3% 2.3M
|
Health Technology
|
| O: -0.71%
H: 0.08%
C: -1.07%
GSK | News | $41.165 1.42% 1.3M
|
Health Technology
|
| O: 0.36%
H: 0.28%
C: -1.17%
ABBV | News | $170.2 1.38% 2M
|
Health Technology
|
| O: -0.59%
H: 0.44%
C: -0.48%
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: 0.0%
america sinusitis growth market
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.56 162.07% 21M
|
AGBA | $2.74 119.2% 52M
|
Finance
CZOO | $9.07 81.76% 22M
|
EDBL | News | $6.56 74.47% 1.8M
|
OPRT | News | $3.37 49.78% 8.9M
|
Finance
MTC | $2.21 41.67% 5.6M
|
Technology Services
VNRX | $0.7945 32.42% 3.1M
|
Health Technology
MLEC | $1.81 29.29% 2.8M
|
n/a
BTCM | $3.45 27.78% 640K
|
Arts, Entertainment, and Recrea...
PALI | $6.29 27.59% 22M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.